🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

3 big dividend moves: Royalty Pharma, EMCOR

Published 10/01/2023, 12:27
© Reuters.
KFFB
-
EME
-
RPRX
-

Here are 3 big dividend hikes to start the week, all covered in real time on InvestingPro.

Royalty Pharma Plc (NASDAQ:RPRX) hiked its quarterly dividend by 5.3% to $0.20 per share, or $0.8 annualized, for an annual yield of 2.1%. The dividend will be payable on March 15, 2023, to stockholders of record on February 16, 2023, with an ex-dividend date of February 15, 2023. The company also provided an update on its business performance, including recent key accomplishments and the full-year 2022 outlook, expecting strong financial performance for the year. As a result, shares closed more than 2% higher yesterday.

EMCOR Group (NYSE:EME) declared a quarterly dividend of $0.15 per share, or $0.6 annualized, for an annual yield of 0.4%. The dividend will be payable on January 31, 2023, to stockholders of record on January 17, 2023, with an ex-dividend date of January 13, 2023.

Kentucky First Federal Bancorp (NASDAQ:KFFB) declared a quarterly dividend of $0.10 per share, or $0.4 annualized, for an annual yield of 6.1%. The dividend will be payable on February 16, 2023, to stockholders of record on January 31, 2023, with an ex-dividend date of January 30, 2023.

***

For tools, data, and content to help you make better investing decisions, try InvestingPro.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.